Moving an Existing Supplement Formula to a New Manufacturer
Changing supplement manufacturers is not simply a matter of sending the existing formula to a new factory and asking for the same product.
For an established supplement brand, the formula may already be commercially proven. However, moving the product to a new manufacturer is a technology transfer process, not simply a formula handover. The new manufacturer needs to confirm whether the raw materials, manufacturing process, packaging, quality specifications and supporting documentation can be transferred without creating unexpected changes.
A successful transfer should therefore be treated as a technical and manufacturing feasibility project, rather than simply a new production order.
1. What Actually Needs to Be Transferred?
An existing supplement product usually involves more than an ingredient list.
The transfer may include the formula, raw material specifications, finished-product specifications, manufacturing process, testing requirements, packaging information and quality documentation.
The brand should also confirm that it has the right to transfer the relevant formula, specifications, technical documents and supplier information to the new manufacturer. If proprietary ingredients, licensed technologies or supplier-controlled specifications are involved, the applicable transfer rights and confidentiality requirements should be clarified before technical work begins.
If the brand can provide existing COAs, testing reports, stability information or previous batch records where available, the new manufacturer can usually assess the project more efficiently.
The completeness of the existing specification package is therefore one of the first factors affecting the transfer process.
2. Existing Formula Does Not Always Mean Identical Manufacturing
Two manufacturers can use the same ingredient names while producing different manufacturing results.
Differences in raw material source, standardization, particle size, carrier content, bulk density or moisture can affect how a powder behaves during blending and filling. Manufacturing equipment and process parameters can also differ between factories. These differences may affect the product’s Critical Quality Attributes (CQAs), such as assay, blend uniformity, fill weight, physical characteristics, dissolution or sensory properties, depending on the dosage form.
For this reason, the new manufacturer should review the actual raw material specifications rather than simply copying the ingredient names from the original formula. The goal is to establish comparability between the existing product and the transferred product, rather than assuming that the same ingredient names will produce identical results. The proposed materials and process should also be assessed for their ability to support the existing finished-product specifications and maintain the relevant Critical Quality Attributes (CQAs).
3. Step 1 — Specification Review
The transfer normally starts with a detailed review of the existing product specification.
The manufacturer needs to understand the formula composition, ingredient dosages, dosage form, finished-product requirements, testing standards, packaging configuration and target market. A preliminary regulatory and target-market review should also be completed at this stage to identify any ingredient, dosage, classification, labeling or claim-related issues before the transferred specification is finalized.
This review can also identify missing information early.
For example, a brand may have a commercial formula sheet showing the ingredient names and dosages but not the detailed raw material specifications used by the original factory. In this situation, additional technical work may be required before the formula can be transferred accurately.
4. Step 2 — Raw Material Equivalence
Raw material equivalence is often one of the most important parts of a manufacturing transfer.
The new manufacturer may need to compare the identity, source, grade, standardization, active markers, extract ratios, carrier content and analytical specifications of key ingredients.
For botanical extracts, the review may go beyond the ingredient name and extract ratio (e.g., 10:1 vs 20:1) to include carrier composition such as maltodextrin, active-marker HPLC profiles, applicable heavy-metal specifications and particle or mesh-size distribution where relevant.
The objective is not necessarily to use exactly the same supplier as the original manufacturer. Instead, the proposed material needs to meet the required specification, remain comparable to the original material where relevant, and be suitable for the intended manufacturing process and target market.
If an exact equivalent is unavailable, the manufacturer may need to evaluate an alternative material through additional technical review, pilot production and comparability assessment before commercial approval.
5. Step 3 — Process Transfer
The formula is only one part of the product.
The new factory also needs to determine whether its equipment and manufacturing process can produce the product consistently.
For capsules, this may involve powder flowability, bulk density, blend uniformity, fill weight and capsule size. Tablets can require additional consideration of compression characteristics, hardness and friability. Powders, gummies, soft chews and liquids each have their own processing and filling considerations.
The goal is not necessarily to reproduce every machine setting from the previous manufacturer. It is to achieve the required finished-product specifications using a process that is stable and repeatable at the new facility.
6. Step 4 — Pilot Batch
A pilot batch provides an opportunity to verify whether the transferred formula and process work under the new manufacturer’s production conditions.
Depending on the product, the pilot may be used to evaluate blend uniformity, fill weight, physical characteristics, sensory performance, packaging performance and finished-product testing. The results can also be compared with the existing product or historical batch data to assess product comparability and Critical Quality Attributes (CQAs) where appropriate.
Pilot production is particularly useful when the new manufacturer is using different raw material sources, equipment or process parameters.
It can identify problems before the project moves into commercial production, where changes become more expensive and time-consuming. Where required by the quality agreement or commercial arrangement, the pilot results should be reviewed and approved by the brand before the transferred product moves to commercial production.
Where the transfer involves changes in raw materials, manufacturing conditions or packaging, stability bridging may also be considered to determine whether the transferred product remains comparable over its intended shelf life. The need for additional stability work depends on the extent of the change, existing stability data, product characteristics and target-market requirements.
7. Step 5 — Packaging Compatibility
Packaging should also be reviewed as part of the manufacturing transfer.
If the brand wants to keep its existing bottles, blister packs, pouches or stick packs, the new factory should confirm that the components are compatible with its filling and packing equipment and do not create unintended changes to the finished product’s quality or stability.
Bottle dimensions, fill volume, capsule or tablet count, desiccant requirements, label dimensions and closure systems can all affect packaging efficiency.
If new packaging is required, the change can also affect MOQ, artwork approval, supplier lead time, finished-product cost and, where relevant, product stability or packaging-performance requirements.
8. Step 6 — Quality Documentation
Established brands often have quality requirements that need to be transferred together with the formula.
The new manufacturer may need to review raw material COAs, finished-product specifications, testing methods, certificates, batch documentation, stability information and packaging specifications.
The exact documentation depends on the product, target market and commercial agreement.
Where the brand already has defined specifications, any proposed deviation should be identified and discussed before commercial production.
The transfer should also establish how future changes will be controlled. This may include changes to raw materials, suppliers, specifications, manufacturing processes, testing methods, packaging components or other product-critical information. Where applicable, the manufacturer should follow an agreed change-control and notification process before implementing changes that could affect the transferred product.
9. Long-Term Change Control After Transfer
A successful technology transfer should also consider what happens after the first commercial production run.
Over time, raw material suppliers may discontinue products, branded ingredient licensing may change, specifications may be updated, or manufacturing processes may need to be adjusted. These changes should not be treated as routine substitutions without assessing their potential impact on the transferred product.
A practical change-control process should therefore define formula version control, specification changes, supplier changes, regulatory-status changes, change-control notification and, where required, customer approval.
This helps maintain product consistency after the transfer rather than treating the first successful production run as the end of the transfer process.
10. Target-Market and Regulatory Review
A manufacturer transfer is also an opportunity to confirm that the existing product remains suitable for the intended market and that the transferred specification does not create new regulatory or labeling issues.
Ingredient status, dosage, product classification, labeling and claim direction may need to be reviewed, particularly if the product is being transferred for a new market.
This is important because a formula that has already been manufactured successfully in one market does not automatically meet the requirements of another market, including the US, EU, UK, Australia or New Zealand. A successful manufacturing history therefore should not be treated as evidence of automatic regulatory suitability in a different market.
A target-market and regulatory review should therefore be completed before finalizing the transferred specification and packaging direction.
11. What Affects Transfer Cost and Lead Time?
An existing commercial formula can reduce development work, but it does not necessarily mean that the transfer will be immediate or cost-neutral. The actual transfer scope depends on the completeness of the existing documentation, raw material equivalence, process differences, pilot requirements, packaging compatibility and regulatory review.
The overall timeline can be affected by specification review, raw material approval, sourcing, pilot production, testing, packaging availability, artwork approval and documentation review. Production lead time is only one part of the total project timeline.
Cost can also change when the new manufacturer has different raw material sources, production batch requirements, packaging suppliers or testing requirements.
For this reason, the new quotation should be based on the actual transfer scope, rather than simply copying the previous manufacturer’s unit price.
12. A Practical Manufacturing Transfer Workflow
A typical transfer can follow:
Existing Product & Transfer Rights → Specification & Regulatory Review → Raw Material Equivalence → Process Transfer → Pilot Batch → Comparability Assessment → Brand Approval → Packaging & Documentation Review → Commercial Transfer → Change Control
Not every project requires the same level of work.
A straightforward product with complete specifications may transfer relatively efficiently, while a complex formula with proprietary ingredients, incomplete documentation or specialized processing requirements may require additional feasibility work.
The level of work should therefore be determined by the transfer scope and product complexity, rather than by the fact that the formula already exists.
13. What Should an Established Brand Prepare?
Before contacting a new manufacturer, the brand should ideally prepare a Transfer Package containing the current formula and available product specifications, together with information on the dosage form, target market, packaging and expected production quantity.
Existing testing reports, COAs, stability data, previous batch records, packaging specifications and quality requirements can also help the new manufacturer identify potential gaps earlier.
If the product contains proprietary ingredients or supplier-specific materials, these should be identified during the initial review rather than after the quotation has been finalized.
The more complete the transfer package, the more accurately the manufacturer can assess technical feasibility, raw material comparability, MOQ, cost, lead time and potential transfer risks.
FAQ
Q1. Can I use exactly the same formula at a new manufacturer?
Possibly, but the formula alone is not enough to ensure an identical product.
Q2. Do I need a pilot batch when changing manufacturers?
Not always, but it can be valuable when the transfer involves meaningful changes.
Q3. Can the new manufacturer use the same raw material suppliers?
Sometimes, but it depends on availability and commercial conditions.
Q4. Will changing manufacturers change my product cost?
It can.
Q5. How long does a manufacturing transfer take?
There is no fixed timeline.
Q6. What should be included in a supplement manufacturing transfer package?
It should include the key technical, quality, packaging and product information available for the existing product.
Next Step
If you already have a commercial supplement formula and are considering a new manufacturer, the first step should be a Specification & Manufacturing Feasibility Review based on the available Transfer Package.
This can help determine whether the existing product can be transferred as specified, whether raw materials and processes are comparable, what may need to change, and how those changes could affect MOQ, Cost and Lead Time.
Request a Manufacturing Feasibility Review
Share this page to